The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice.
Open accessAbstract
Human antigen-specific CD4+ T cells become autoreactive after treatment with various DNA methylation inhibitors, including 5-azacytidine, procainamide, and hydralazine. This suggests a mechanism that could contribute to the development of some forms of autoimmunity. In this report we have asked whether T cells treated with DNA methylation inhibitors can induce autoimmunity. Murine CD4+ T cells were treated with 5-azacytidine or procainamide and were shown to respond to syngeneic antigen-presenting cells, similar to CD4+ human T cell clones treated with these drugs. Functional characterization demonstrated that cells treated with either drug spontaneously lysed syngeneic macrophages and secreted IL-4, IL-6, and IFN-gamma. Adoptive transfer of 5-azacytidine- or procainamide-treated cells into unirradiated syngeneic recipients induced an immune complex glomerulonephritis and IgG anti-DNA and antihistone antibodies. These experiments demonstrate that T cells treated with either of two distinct DNA methyltransferase inhibitors are sufficient to induce a lupus-like disease. It is possible that the lysis of macrophages, together with the release of cytokines promoting B cell differentiation, contributes to the autoantibody production and immune complex deposition. These results suggest that environmental agents that inhibit DNA methylation could interact with T cells in vivo to produce a lupus-like illness, a mechanism that could have relevance to drug-induced and idiopathic lupus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
T cell tolerance by clonal elimination in the thymus
Kappler, J. W., Roehm, N., & Marrack, P. (1987) · Cell · doi:10.1016/0092-8674(87)90568-x · Cited by 2,211
Murine Models of Systemic Lupus Erythematosus
Theofilopoulos, A. N., & Dixon, F. J. (1985) · Advances in Immunology · doi:10.1016/s0065-2776(08)60342-9 · Cited by 1,550
Heterogeneity of Cytokine Secretion Patterns and Functions of Helper T Cells
Mosmann, T. R., & Coffman, R. L. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60652-5 · Cited by 1,106
Prognostic factors in lupus nephritis
Austin, H. A., Muenz, L. R., Joyce, K. M., Antonovych, T. T., Kullick, M. E., Klippel, J. H., Decker, J. L., & Balow, J. E. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90338-8 · Cited by 803
The Immunology and Pathology of NZB Mice
(1968) · Advances in Immunology · doi:10.1016/s0065-2776(08)60444-7 · Cited by 660
Kaye, J., Porcelli, S., Tite, J., Jones, B., & Janeway, C. A. (1983) · The Journal of experimental medicine · doi:10.1084/jem.158.3.836 · Cited by 640
Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation.
Pezzella, F., Tse, A. G. D., Cordell, J. L., Pulford, K. A. F., Gatter, K. C., & Mason, D. Y. (1990) · Europe PMC (PubMed Central) · Cited by 595
Richardson, B., Scheinbart, L., Strahler, J., Gross, L., Hanash, S., & Johnson, M. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780331109 · Cited by 562
Self-citationAcquisition of immunologic self-tolerance
Schwartz, R. H. (1989) · Cell · doi:10.1016/0092-8674(89)90044-5 · Cited by 477
Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity.
Cornacchia, E., Golbus, J., Maybaum, J., Strahler, J., Hanash, S., & Richardson, B. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.7.2197 · Cited by 420
Self-citation
Cited by
DNA methylation and human disease
Robertson, K. D. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1655 · Cited by 2,864
Phenotypic plasticity and the epigenetics of human disease
Feinberg, A. P. (2007) · Nature · doi:10.1038/nature05919 · Cited by 1,613
“Treatment of viable T cells with 5-aza-2′-deoxycytidine induces a syndrome in mice similar to systemic lupus erythematosi”
BackgroundEpigenetics and gene expression
Gibney, E. R., & Nolan, C. M. (2010) · Heredity · doi:10.1038/hdy.2010.54 · Cited by 1,109
Issa, J.-P. J., Garcia-Manero, G., Giles, F. J., Mannari, R., Thomas, D., Faderl, S., Bayar, E., Lyons, J., Rosenfeld, C. S., Cortes, J., et al. (2004) · Blood · doi:10.1182/blood-2003-03-0687 · Cited by 809
Pan, W., Zhu, S., Yuan, M., Cui, H., Wang, L., Luo, X., Li, J., Zhou, H., Tang, Y., & Shen, N. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904060 · Cited by 561
Zhao, S., Wang, Y., Liang, Y., Zhao, M., Long, H., Ding, S., Yin, H., & Lu, Q. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30196 · Cited by 363
Absher, D. M., Li, X., Waite, L. L., Gibson, A., Roberts, K., Edberg, J., Chatham, W. W., & Kimberly, R. P. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003678 · Cited by 351
The emerging role of epigenetics in human autoimmune disorders
Mazzone, R., Zwergel, C., Artico, M., Taurone, S., Ralli, M., Greco, A., & Mai, A. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0632-2 · Cited by 318
The genetics and epigenetics of autoimmune diseases
Hewagama, A., & Richardson, B. (2009) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.03.007 · Cited by 302
Self-citationBrooks, W. H., Le Dantec, C., Pers, J.-O., Youinou, P., & Renaudineau, Y. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.12.006 · Cited by 298
Demethylation of ITGAL (CD11a) regulatory sequences in systemic lupus erythematosus
Lu, Q., Kaplan, M., Ray, D., Ray, D., Zacharek, S., Gutsch, D., & Richardson, B. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10234 · Cited by 286
Self-citationDeng, C., Lu, Q., Zhang, Z., Rao, T., Attwood, J., Yung, R., & Richardson, B. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10833 · Cited by 284
Self-citationThe cutaneous pathology of lupus erythematosus: a review
Crowson, A. N., & Magro, C. (2001) · Journal of Cutaneous Pathology · doi:10.1034/j.1600-0560.2001.280101.x · Cited by 264
Lu, Q., Wu, A., & Richardson, B. C. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.10.6212 · Cited by 263
Self-citationEpigenetic alterations in autoimmune rheumatic diseases
Ballestar, E. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.16 · Cited by 173
“Azacytidine-treated cells were later found to cause SLE-like disease when transferred to mice”
BackgroundAbnormal T cell signal transduction in systemic lupus erythematosus
Kammer, G. M., Perl, A., Richardson, B. C., & Tsokos, G. C. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10192 · Cited by 139
Self-citationMolecular mechanisms mediated by human endogenous retroviruses (HERVs) in autoimmunity
Balada, E., Ordi‐Ros, J., & Vilardell‐Tarrés, M. (2009) · Reviews in Medical Virology · doi:10.1002/rmv.622 · Cited by 122
Anti-DNA autoantibodies and systemic lupus erythematosus
Blatt, N. B., & Glick, G. D. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00022-4 · Cited by 60
Metadata
- Authors
- Quddus, J., Johnson, K. J., Gavalchin, J., Amento, E. P., Chrisp, C. E., Yung, R. L., & Richardson, B. C.
- Venue
- Journal of Clinical Investigation
- Published
- 1993-07-01
- Volume
- 92
- Issue
- 1
- Pages
- 38-53
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2098976753
- Cited by
- 359
- References
- 36
- FWCI
- 4.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.